Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New online tool helps seniors and doctors weigh mammogram pros and cons

NCT ID NCT06011434

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a website called 'Decide Together' that helps women aged 75 and older and their primary care doctors talk about the benefits and harms of mammography screening. The goal was to support shared decision-making, not to treat or prevent breast cancer. The study enrolled 155 participants, including patients, family members, and doctors.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Mammography Screening Conversation Aid (web-based decision tool)
What this could lead to
If successful, this tool could help older women and their doctors make more informed, personal decisions about mammography screening.
What could go wrong
This is a small, completed behavioral study (155 participants) testing a conversation aid, not a treatment. Results may not apply to all populations or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

155 people

The number who actually took part.

Started

May 2024

Finished

Dec 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Primary care practices at Beth Israel Deaconess Medical Center

Ages

75 to 89 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Participant Inclusion Criteria: * English-speaking * Aged 75 - 89 years * Seen by an attending-level (non-resident) seen at the recruitment practices who have the -Ability and willingness to provide verbal consent. Participant Family Members Inclusion Criteria: * Family member of patient that has agreed to participate in the study * Age \>18 * English speaking * Ability and willingness to provide verbal consent Primary Care Provider Inclusion Criteria: * Non-resident physician, nurse practitioner, or physician assistant -\>18 years old * English speaking * Cares for a panel of patients that includes women \>75 years at one of the recruitment practices * Ability and willingness to provide verbal consent Participant Exclusion Criteria: * Last mammogram \<6 or \>30 months (so that participants may be contemplative of their next mammogram) * History of dementia * Incapacity for informed consent * History of invasive or non-invasive breast cancer * Last mammogram was abnormal * Non-English speaking * Already chose to stop being screened (documented in medical records or scores of 1-3 \[do not intend to be screened\] on a validate 15 point intentions to be screened scale.) * PCP unwilling to have patient participate * In hospice * PCP not willing to participate * Psychiatric illness situations that would limit compliance with study requirements Participant Family Member Exclusion Criteria: * Age \<18 * Non-English speaking * Psychiatric illness situations that would limit compliance with study requirements Primary Care Provider Exclusion Criteria: * Resident physician * Psychiatric illness situations that would limit compliance with study requirements

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Breast cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Beth Israel Deaconess Medical Center

    Boston, Massachusetts, 02215, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.